Adsorption acellular DTP (three-component) combined vaccine(Changchun Baike)
吸附无细胞百白破(三组分)联合疫苗(长春百克)
Report date: 2025/06/06 20:01:13
Base Information
Drug NameAdsorption acellular DTP (three-component) combined vaccine(Changchun Baike)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChangchun Bcht Biotechnology Co
China Registration ClassN/A
Develop Information
Active CompaniesChangchun Bcht Biotechnology Co
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A